Journal profile · PHARMACOLOGY & PHARMACY
Journal of Pharmaceutical Health Care and Sciences
ISSN 2055-0294 · BMC · United Kingdom
Journal of Pharmaceutical Health Care and Sciences: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.3 (journal website); fully open access; APC about USD 2,490; median 79 days to acceptance (102 articles, last 24 months); 126 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Journal of Pharmaceutical Health Care and Sciences is published by BMC and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pharmaceutical Practices and Patient Outcomes, Pharmacy and Medical Practices and Medication Adherence and Compliance, together about 28.7% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Journal of Pharmaceutical Health Care and Sciences (JPHCS) is an open access, peer-reviewed journal that encompasses clinical pharmacy as well as clinical and experimental pharmacotherapy. JPHCS welcomes Research articles, Review articles (invitation only), Case reports and Short communications. Topical areas of interest include: Outcome research on pharmacotherapy and pharmaceutical health care Rational and appropriate pharmacotherapy in relation to clinical and/or experimental indices Clinical pharmacy Pharmacoepidemiology Pharmacoeconomics Drug informatics Pharmacy services research Medication management Other aspects of pharmaceutical health care and sciences JPHCS is the official publication of the Japanese Society of Pharmaceutical Health Care and Sciences.
From the journal's Aims & Scope
Research area (LetPub): PHARMACOLOGY & PHARMACY
Editor-in-chief Hiroaki IkesuePublisher website
Editorial board by country: none in mainland China; most named Japan 64, United States 2, Taiwan, China 1 (67 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmaceutical Practices and Patient OutcomesMedicine13.3%
- Pharmacy and Medical PracticesPharmacology, Toxicology and Pharmaceutics9.8%
- Medication Adherence and ComplianceMedicine5.6%
- Pharmacovigilance and Adverse Drug ReactionsPharmacology, Toxicology and Pharmaceutics5.6%
- Antibiotics Pharmacokinetics and EfficacyMedicine5.3%
- Antibiotic Use and ResistanceImmunology and Microbiology4.2%
- Nausea and vomiting managementMedicine4.1%
- Safe Handling of Antineoplastic DrugsHealth Professions4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbaseCASPublisher website
Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 1.3Publisher website ·
- 5-year impact factor (publisher) 2025
- 1.4Publisher website ·
- CiteScore 2026-06
- 1.5LetPub ·
- SJR 2026-06
- 0.37LetPub ·
- SNIP 2026-06
- 0.63LetPub ·
- h-index
- 28OpenAlex ·
- i10-index
- 125OpenAlex ·
- 2-year mean citedness
- 1.62OpenAlex ·
- Self-citation rate
- 7.7%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 122LetPub ·
- Downloads per year (publisher) 2025
- 503,100Publisher website ·
Articles by year OpenAlex count · 628 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 98 | 98 | 27 |
| 2025 | 126 | 126 | 180 |
| 2024 | 82 | 82 | 288 |
| 2023 | 52 | 52 | 192 |
| 2022 | 37 | 37 | 276 |
| 2021 | 48 | 48 | 472 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
79 daysMedian, submission to acceptance · P25–P75 53 days – 121 days
- Acceptance to online
- median 10 days (102 articles)
- Submission to online
- median 95 days
- Sample
- 102 articles with submission and acceptance dates (246 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 8 weeksLetPub ·
- Submission to first decision
- 5 daysPublisher website ·
- Submission to publication (journal-reported)
- about 8 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 2,090 / USD 2,490 / GBP 1,690 | Yes | CC BY, CC0 | |
| OpenAlex | USD 2,490 / EUR 2,090 / GBP 1,690 | — | — | |
| LetPub | EUR 2,090 / USD 2,490 / GBP 1,690 | Yes | — | |
| Publisher website | GBP 1,690 / USD 2,490 / EUR 2,090 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted4
- brief reportFormatting guidelines for specific article types can be found below. Research Case report Review Brief ReportLength not stated
- case reportFormatting guidelines for specific article types can be found below. Research Case report Review Brief ReportLength not stated
- researchFormatting guidelines for specific article types can be found below. Research Case report Review Brief ReportLength not stated
- reviewFormatting guidelines for specific article types can be found below. Research Case report Review Brief ReportLength not stated
Policy excerpts from the journal's websiteData availability, License & copyright, Open access, Peer review
- Data availability Formatting the 'Availability of data and materials' section of your manuscript
The journal follows a CC0 data policy; the Creative Commons CC0 1.0 Public Domain Dedication waiver applies to all published data. Model summary
The following format for the 'Availability of data and materials section of your manuscript should be used:
Source ↗Publisher website ·- License & copyright Licensing and copyright
Open access articles are published under a CC BY (Creative Commons Attribution 4.0 International) licence. Model summary
Creative Commons licences Open access articles in Springer Nature journals are published under Creative Commons licences. These provide an industry-standard framework to support easy re-use of open access material. Under Creative Commons licences, authors retain copyright of their articles. Journal of Pharmaceutical Health Care and Sciences articles are published open access under a CC BY (Creativ…
Source ↗Publisher website ·- Open access Benefits of open access
Publishing open access (OA) offers a number of benefits, including greater reach and readership for your work: Cited more 1.6x more citations of OA articles than non-OA articles across all subjects Downloaded more 4x more downloads of OA articles than non-OA articles Greater impact 2.5x more Altmetric attention. OA articles attracted 1.9x more news mentions and 1.2x more policy mentions Open acces…
Source ↗Publisher website ·- Peer review Peer review policy
Peer review is the process used to evaluate the quality of a manuscript before publication. Independent researchers in the relevant field assess submitted manuscripts to check their validity and robustness. Their feedback guides editors in making publication decisions. Typically, two or more experts evaluate each manuscript based on three main criteria: scientific robustness: is the research metho…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- BMC
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2055-0294
- Society / sponsor
- Japanese Society of Pharmaceutical Health Care and Sciences
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Journal of Pharmaceutical Health Care and Sciences
What CAS zone is Journal of Pharmaceutical Health Care and Sciences in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Pharmaceutical Health Care and Sciences is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Pharmaceutical Health Care and Sciences?
The journal's website gives an impact factor of 1.3 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 1.5, h-index 28.
How long does peer review take at Journal of Pharmaceutical Health Care and Sciences?
Based on the dates recorded on 102 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 79 days (interquartile range 53–121 days); authors report an average review time of about 8 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Journal of Pharmaceutical Health Care and Sciences based?
Of the 67 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Japan (64), United States (2) and Taiwan, China (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Pharmaceutical Health Care and Sciences?
According to LetPub and DOAJ records, Journal of Pharmaceutical Health Care and Sciences is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Embase and CAS; that list has not been checked against each database.
Is Journal of Pharmaceutical Health Care and Sciences open access, and what is the APC?
Journal of Pharmaceutical Health Care and Sciences is a fully open-access journal. APC about USD 2,490.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .